Jason R. Plemel

Over-the-counter anti-oxidant therapies for use in multiple sclerosis: A systematic review.

Progressive multiple sclerosis: from pathophysiology to therapeutic strategies.

The fate and function of oligodendrocyte progenitor cells after traumatic spinal cord injury.

Central Nervous System Remyelination: Roles of Glia and Innate Immune Cells.

Microglia response following acute demyelination is heterogeneous and limits infiltrating macrophage dispersion.

Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system.

Correction to: Niacin-mediated rejuvenation of macrophage/microglia enhances remyelination of the aging central nervous system.

Aging-Exacerbated Acute Axon and Myelin Injury Is Associated with Microglia-Derived Reactive Oxygen Species and Is Alleviated by the Generic Medication Indapamide.

Microglia Diversity in Health and Multiple Sclerosis.

The CD33 short isoform is a gain-of-function variant that enhances Aβ phagocytosis in microglia.

Regulation of microglia population dynamics throughout development, health, and disease.

An X-ray for myelin.

Myelin Quantification in White Matter Pathology of Progressive Multiple Sclerosis Post-Mortem Brain Samples: A New Approach for Quantifying Remyelination.

Central nervous system macrophages in progressive multiple sclerosis: relationship to neurodegeneration and therapeutics.

Oligodendrocyte death and myelin loss in the cuprizone model: an updated overview of the intrinsic and extrinsic causes of cuprizone demyelination.

Towards a definition of microglia heterogeneity.

Editorial: Non-neuronal cell heterogeneity in the nervous system during health and disease.

Sex differences in the inflammatory response of the mouse DRG and its connection to pain in experimental autoimmune encephalomyelitis.

Single-cell microglial transcriptomics during demyelination defines a microglial state required for lytic carcass clearance.